Joan D Beckman
@jdbeckman.bsky.social
470 followers
580 following
59 posts
Lois & Richard King Assistant Professor of Medicine at University of Minnesota- hematology physician scientist, mother, cat lady, & ND native. Excited for Gopher and Bison sports, sickle cell and MPN vascular biology, and rare bleeding disorders.
Posts
Media
Videos
Starter Packs
Reposted by Joan D Beckman
Joan D Beckman
@jdbeckman.bsky.social
· Jul 26
Reposted by Joan D Beckman
Reposted by Joan D Beckman
Joan D Beckman
@jdbeckman.bsky.social
· Jul 1
Joan D Beckman
@jdbeckman.bsky.social
· Jun 24
Reposted by Joan D Beckman
Kumail Nanjiani
@kumail.bsky.social
· Jun 21
Reposted by Joan D Beckman
Reposted by Joan D Beckman
Reposted by Joan D Beckman
Joan D Beckman
@jdbeckman.bsky.social
· Jun 4
Ropeginterferon Alfa-2b Demonstrates Superior Efficacy and Safety to Anagrelide as Second-Line Therapy for Essential Thrombocythemia
The phase 3 SURPASS-ET trial results show superior efficacy and safety of ropeginterferon alfa-2b compared with anagrelide as second-line therapy for essential thrombocythemia (Abstract 6500).
dailynews.ascopubs.org
Reposted by Joan D Beckman